Certified by Founder Lodge
Odimma Therapeutics
France - ILLKIRCH GRAFFENSTADEN, Grandest
START UP
1 Disclosed Funding Rounds $2,213,210
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy.
Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this
Bpifrance
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
